Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nkx2-1
|
ENSMUSG00000001496.9 | NK2 homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_56537042_56537193 | Nkx2-1 | 209 | 0.529085 | 0.40 | 2.7e-03 | Click! |
chr12_56535998_56536318 | Nkx2-1 | 750 | 0.376495 | 0.37 | 5.9e-03 | Click! |
chr12_56533499_56533715 | Nkx2-1 | 1499 | 0.240326 | 0.37 | 6.0e-03 | Click! |
chr12_56536742_56536914 | Nkx2-1 | 80 | 0.875324 | 0.29 | 3.1e-02 | Click! |
chr12_56533721_56533872 | Nkx2-1 | 1310 | 0.268165 | 0.22 | 1.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_14660294_14660574 | 13.24 |
Dlgap2 |
DLG associated protein 2 |
82319 |
0.09 |
chr10_77464541_77465063 | 10.79 |
Gm35920 |
predicted gene, 35920 |
6885 |
0.17 |
chr8_95810251_95810682 | 10.47 |
4930513N10Rik |
RIKEN cDNA 4930513N10 gene |
1433 |
0.22 |
chr11_79771332_79771811 | 10.37 |
9130204K15Rik |
RIKEN cDNA 9130204K15 gene |
11316 |
0.16 |
chr10_67785830_67785981 | 10.05 |
Gm49766 |
predicted gene, 49766 |
156 |
0.51 |
chr15_102302559_102302908 | 10.05 |
Gm49480 |
predicted gene, 49480 |
6029 |
0.08 |
chr4_142173951_142174551 | 9.73 |
Gm13062 |
predicted gene 13062 |
6351 |
0.2 |
chr9_32646902_32647120 | 9.66 |
Ets1 |
E26 avian leukemia oncogene 1, 5' domain |
10763 |
0.16 |
chr10_88335126_88335719 | 9.61 |
Dram1 |
DNA-damage regulated autophagy modulator 1 |
21574 |
0.14 |
chr9_118741385_118741611 | 9.61 |
Itga9 |
integrin alpha 9 |
29841 |
0.19 |
chr9_67247492_67247646 | 9.00 |
Mir190a |
microRNA 190a |
10843 |
0.21 |
chr13_45627470_45627741 | 8.90 |
Gmpr |
guanosine monophosphate reductase |
81452 |
0.1 |
chr11_85832197_85833021 | 8.74 |
Tbx2 |
T-box 2 |
58 |
0.84 |
chr4_57067978_57068132 | 8.61 |
Epb41l4b |
erythrocyte membrane protein band 4.1 like 4b |
2504 |
0.33 |
chr10_77441115_77441597 | 8.56 |
Gm35920 |
predicted gene, 35920 |
16561 |
0.15 |
chr8_91967490_91967848 | 8.55 |
Gm36670 |
predicted gene, 36670 |
24200 |
0.14 |
chr1_189405206_189405485 | 8.45 |
Kcnk2 |
potassium channel, subfamily K, member 2 |
3072 |
0.28 |
chr7_45103719_45104207 | 8.40 |
Fcgrt |
Fc receptor, IgG, alpha chain transporter |
112 |
0.85 |
chr11_88909803_88909962 | 8.19 |
Scpep1os |
serine carboxypeptidase 1, opposite strand |
3954 |
0.15 |
chr9_63563534_63563685 | 8.16 |
Gm16759 |
predicted gene, 16759 |
32257 |
0.14 |
chr17_12467739_12467890 | 8.11 |
C030013G03Rik |
RIKEN cDNA C030013G03 gene |
870 |
0.62 |
chr12_111320582_111320851 | 8.03 |
Cdc42bpb |
CDC42 binding protein kinase beta |
6179 |
0.17 |
chr10_61386219_61386644 | 8.02 |
Pald1 |
phosphatase domain containing, paladin 1 |
2901 |
0.16 |
chr6_94203901_94204242 | 7.98 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
78954 |
0.1 |
chr2_128727670_128727833 | 7.94 |
Gm14011 |
predicted gene 14011 |
25954 |
0.13 |
chr11_102643877_102644083 | 7.87 |
Gm22920 |
predicted gene, 22920 |
15700 |
0.09 |
chr7_116221705_116221861 | 7.84 |
Plekha7 |
pleckstrin homology domain containing, family A member 7 |
15883 |
0.19 |
chr15_38950893_38951406 | 7.80 |
Gm49097 |
predicted gene, 49097 |
12527 |
0.14 |
chr2_26342024_26342508 | 7.74 |
Gpsm1 |
G-protein signalling modulator 1 (AGS3-like, C. elegans) |
23 |
0.95 |
chr13_56923085_56923236 | 7.74 |
Gm22777 |
predicted gene, 22777 |
7788 |
0.25 |
chr1_74180094_74180273 | 7.61 |
Cxcr1 |
chemokine (C-X-C motif) receptor 1 |
13052 |
0.11 |
chr16_12697258_12697682 | 7.56 |
Gm38619 |
predicted gene, 38619 |
6898 |
0.28 |
chr4_96806874_96807205 | 7.54 |
Gm12695 |
predicted gene 12695 |
21853 |
0.24 |
chr18_14240028_14240327 | 7.50 |
8430422H06Rik |
RIKEN cDNA 8430422H06 gene |
7868 |
0.25 |
chr4_100101880_100102395 | 7.25 |
Ror1 |
receptor tyrosine kinase-like orphan receptor 1 |
6346 |
0.22 |
chr16_95855291_95855553 | 7.22 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
9652 |
0.19 |
chr3_108830561_108830749 | 7.21 |
Stxbp3 |
syntaxin binding protein 3 |
9796 |
0.15 |
chr5_115572995_115573302 | 7.16 |
Mir7029 |
microRNA 7029 |
7801 |
0.1 |
chr6_71658356_71658548 | 7.09 |
Gm44768 |
predicted gene 44768 |
14226 |
0.12 |
chr10_88622683_88622890 | 7.09 |
Mybpc1 |
myosin binding protein C, slow-type |
17634 |
0.1 |
chr15_85156170_85156533 | 7.05 |
Gm19277 |
predicted gene, 19277 |
219 |
0.92 |
chr19_55168611_55168762 | 6.88 |
Tectb |
tectorin beta |
12047 |
0.17 |
chr4_119512974_119513197 | 6.88 |
Gm12956 |
predicted gene 12956 |
3024 |
0.12 |
chr5_77155017_77155198 | 6.83 |
Chaer1 |
cardiac hypertrophy associated epigenetic regulator 1 |
14855 |
0.13 |
chr6_92468381_92468552 | 6.80 |
Prickle2 |
prickle planar cell polarity protein 2 |
12926 |
0.26 |
chr9_46016716_46016867 | 6.76 |
Sik3 |
SIK family kinase 3 |
3791 |
0.17 |
chr6_97508169_97508320 | 6.75 |
Frmd4b |
FERM domain containing 4B |
20439 |
0.18 |
chr2_161004440_161004617 | 6.71 |
Chd6 |
chromodomain helicase DNA binding protein 6 |
3965 |
0.21 |
chr2_119999857_120000008 | 6.63 |
Mapkbp1 |
mitogen-activated protein kinase binding protein 1 |
11755 |
0.11 |
chr1_93162040_93162233 | 6.62 |
Mab21l4 |
mab-21-like 4 |
1188 |
0.36 |
chr13_37460302_37460827 | 6.61 |
Gm29458 |
predicted gene 29458 |
7356 |
0.1 |
chr16_95244705_95244856 | 6.59 |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
12778 |
0.19 |
chr16_32736242_32736393 | 6.42 |
Muc4 |
mucin 4 |
120 |
0.95 |
chr10_76633731_76633882 | 6.39 |
Col6a2 |
collagen, type VI, alpha 2 |
10176 |
0.15 |
chr9_110689249_110689827 | 6.37 |
Gm35715 |
predicted gene, 35715 |
14584 |
0.1 |
chr16_31131507_31131675 | 6.36 |
Gm18237 |
predicted gene, 18237 |
26279 |
0.14 |
chr8_126837418_126837907 | 6.35 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
1571 |
0.42 |
chr16_38624391_38624551 | 6.34 |
Tmem39a |
transmembrane protein 39a |
36432 |
0.12 |
chr5_53466987_53467162 | 6.33 |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
922 |
0.6 |
chr11_115836694_115837008 | 6.31 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
2528 |
0.15 |
chr7_100979263_100979481 | 6.30 |
P2ry6 |
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
4723 |
0.16 |
chr2_116942429_116942719 | 6.30 |
Gm25514 |
predicted gene, 25514 |
25599 |
0.15 |
chrX_50968307_50968473 | 6.30 |
Frmd7 |
FERM domain containing 7 |
25680 |
0.19 |
chr5_41621861_41622025 | 6.27 |
Rab28 |
RAB28, member RAS oncogene family |
5559 |
0.32 |
chr9_21332556_21332826 | 6.25 |
Slc44a2 |
solute carrier family 44, member 2 |
5137 |
0.1 |
chr2_161038075_161038238 | 6.22 |
Chd6 |
chromodomain helicase DNA binding protein 6 |
8608 |
0.2 |
chr9_105764254_105764459 | 6.22 |
Gm38314 |
predicted gene, 38314 |
36571 |
0.14 |
chr13_98699446_98699752 | 6.21 |
Tmem171 |
transmembrane protein 171 |
4765 |
0.15 |
chr10_110400663_110401061 | 6.21 |
Gm47338 |
predicted gene, 47338 |
21354 |
0.22 |
chr2_122109778_122110051 | 6.21 |
Spg11 |
SPG11, spatacsin vesicle trafficking associated |
8382 |
0.15 |
chr13_119613872_119614873 | 6.13 |
Gm48265 |
predicted gene, 48265 |
900 |
0.48 |
chr5_24053356_24053509 | 6.12 |
Fam126a |
family with sequence similarity 126, member A |
22742 |
0.12 |
chr8_90013834_90014051 | 6.09 |
Tox3 |
TOX high mobility group box family member 3 |
334184 |
0.01 |
chr7_143919129_143919287 | 6.06 |
Mir6404 |
microRNA 6404 |
13907 |
0.17 |
chr5_119651194_119652007 | 6.05 |
Gm16064 |
predicted gene 16064 |
5466 |
0.15 |
chr1_192789049_192789578 | 6.03 |
Hhat |
hedgehog acyltransferase |
18090 |
0.14 |
chr18_38867099_38867250 | 5.98 |
Fgf1 |
fibroblast growth factor 1 |
171 |
0.96 |
chr3_82112576_82112773 | 5.97 |
Mir7010 |
microRNA 7010 |
6365 |
0.2 |
chr6_30622158_30622633 | 5.95 |
Cpa5 |
carboxypeptidase A5 |
9840 |
0.12 |
chr1_166002288_166003185 | 5.95 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr8_33905789_33906327 | 5.95 |
Rbpms |
RNA binding protein gene with multiple splicing |
14294 |
0.16 |
chr11_74756725_74756917 | 5.94 |
Mettl16 |
methyltransferase like 16 |
14009 |
0.13 |
chr11_8500924_8501101 | 5.92 |
Tns3 |
tensin 3 |
32337 |
0.24 |
chr9_21329116_21329292 | 5.92 |
Slc44a2 |
solute carrier family 44, member 2 |
8456 |
0.09 |
chr10_76634079_76634294 | 5.89 |
Col6a2 |
collagen, type VI, alpha 2 |
10556 |
0.15 |
chr8_44709121_44709434 | 5.88 |
Gm26089 |
predicted gene, 26089 |
107444 |
0.07 |
chr4_43729845_43730000 | 5.85 |
Spaar |
small regulatory polypeptide of amino acid response |
112 |
0.91 |
chr17_26225262_26225440 | 5.85 |
Gm3946 |
predicted gene 3946 |
1640 |
0.15 |
chr14_10006414_10006568 | 5.83 |
Gm48430 |
predicted gene, 48430 |
12180 |
0.27 |
chr17_45020295_45020463 | 5.82 |
Gm35097 |
predicted gene, 35097 |
126858 |
0.05 |
chr18_12225620_12225777 | 5.78 |
Npc1 |
NPC intracellular cholesterol transporter 1 |
1611 |
0.32 |
chr19_56817796_56818219 | 5.77 |
Ccdc186 |
coiled-coil domain containing 186 |
4183 |
0.2 |
chr2_148018222_148018401 | 5.74 |
9030622O22Rik |
RIKEN cDNA 9030622O22 gene |
19959 |
0.17 |
chr3_104372484_104372636 | 5.74 |
Gm5546 |
predicted gene 5546 |
5947 |
0.17 |
chr18_58162064_58162437 | 5.74 |
Fbn2 |
fibrillin 2 |
38455 |
0.2 |
chr15_102451811_102451962 | 5.65 |
Amhr2 |
anti-Mullerian hormone type 2 receptor |
273 |
0.82 |
chr15_81067030_81067287 | 5.64 |
Mrtfa |
myocardin related transcription factor A |
146 |
0.95 |
chr16_10337521_10337745 | 5.62 |
Gm1600 |
predicted gene 1600 |
6348 |
0.17 |
chr11_84028739_84028900 | 5.55 |
Synrg |
synergin, gamma |
2164 |
0.3 |
chr16_4521826_4522017 | 5.54 |
Srl |
sarcalumenin |
1142 |
0.44 |
chr9_97680001_97680152 | 5.53 |
Gm25607 |
predicted gene, 25607 |
240449 |
0.02 |
chr9_62007225_62007376 | 5.53 |
Paqr5 |
progestin and adipoQ receptor family member V |
19501 |
0.19 |
chr9_61655666_61655928 | 5.52 |
Gm47241 |
predicted gene, 47241 |
107287 |
0.06 |
chr2_180322679_180323286 | 5.47 |
Gata5os |
GATA binding protein 5, opposite strand |
9875 |
0.12 |
chr17_24020724_24021065 | 5.47 |
Gm25092 |
predicted gene, 25092 |
2434 |
0.11 |
chr4_137506776_137506927 | 5.44 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
15608 |
0.14 |
chr19_24050664_24050815 | 5.41 |
1700021P04Rik |
RIKEN cDNA 1700021P04 gene |
14054 |
0.17 |
chr18_12298119_12298309 | 5.41 |
Ankrd29 |
ankyrin repeat domain 29 |
2223 |
0.26 |
chr9_59696442_59696717 | 5.38 |
Gramd2 |
GRAM domain containing 2 |
11058 |
0.13 |
chr7_18900560_18900845 | 5.38 |
Ccdc61 |
coiled-coil domain containing 61 |
6743 |
0.1 |
chr12_103671079_103671233 | 5.38 |
Serpina16 |
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 16 |
4308 |
0.12 |
chr6_127991516_127991845 | 5.37 |
Tspan9 |
tetraspanin 9 |
24863 |
0.15 |
chr17_28035009_28035397 | 5.36 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
5572 |
0.13 |
chr14_20803051_20803202 | 5.36 |
Gm30108 |
predicted gene, 30108 |
8887 |
0.13 |
chr15_10817918_10818069 | 5.36 |
Gm19276 |
predicted gene, 19276 |
3166 |
0.3 |
chr3_41489546_41489740 | 5.35 |
Platr4 |
pluripotency associated transcript 4 |
1167 |
0.38 |
chr6_99379027_99379368 | 5.35 |
Gm20705 |
predicted gene 20705 |
9302 |
0.24 |
chr16_30039936_30040304 | 5.34 |
9030404E10Rik |
RIKEN cDNA 9030404E10 gene |
641 |
0.67 |
chr8_83458314_83458676 | 5.33 |
Scoc |
short coiled-coil protein |
104 |
0.95 |
chr4_133104265_133104462 | 5.32 |
Wasf2 |
WAS protein family, member 2 |
26142 |
0.14 |
chr12_17318527_17318803 | 5.31 |
Atp6v1c2 |
ATPase, H+ transporting, lysosomal V1 subunit C2 |
6000 |
0.16 |
chr6_30621638_30621803 | 5.28 |
Cpa5 |
carboxypeptidase A5 |
9165 |
0.12 |
chr17_10094319_10094519 | 5.26 |
Qk |
quaking |
119155 |
0.06 |
chr7_139258503_139258654 | 5.25 |
Pwwp2b |
PWWP domain containing 2B |
7221 |
0.16 |
chr9_75234433_75234737 | 5.25 |
Myo5c |
myosin VC |
2509 |
0.26 |
chr9_99685299_99685475 | 5.23 |
Gm16004 |
predicted gene 16004 |
23012 |
0.14 |
chr7_74484118_74484277 | 5.22 |
Slco3a1 |
solute carrier organic anion transporter family, member 3a1 |
20138 |
0.25 |
chr8_124691734_124691926 | 5.21 |
Ttc13 |
tetratricopeptide repeat domain 13 |
9300 |
0.15 |
chr11_72413067_72413411 | 5.21 |
Smtnl2 |
smoothelin-like 2 |
1526 |
0.28 |
chr14_25270361_25270908 | 5.20 |
Gm26660 |
predicted gene, 26660 |
108001 |
0.05 |
chr5_91607966_91608133 | 5.20 |
Parm1 |
prostate androgen-regulated mucin-like protein 1 |
90434 |
0.07 |
chr10_75378810_75378961 | 5.17 |
Upb1 |
ureidopropionase, beta |
22230 |
0.14 |
chr17_31889546_31889716 | 5.17 |
Gm50000 |
predicted gene, 50000 |
9547 |
0.14 |
chr1_164413610_164413909 | 5.17 |
Gm37411 |
predicted gene, 37411 |
10954 |
0.15 |
chr12_12509201_12509901 | 5.16 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
116936 |
0.06 |
chr5_148361109_148361516 | 5.16 |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
10234 |
0.23 |
chr13_64155195_64155660 | 5.15 |
Zfp367 |
zinc finger protein 367 |
2225 |
0.18 |
chr3_97062885_97063210 | 5.15 |
4930573H18Rik |
RIKEN cDNA 4930573H18 gene |
29738 |
0.12 |
chr18_36342380_36342857 | 5.14 |
Cystm1 |
cysteine-rich transmembrane module containing 1 |
38 |
0.98 |
chr8_11248851_11249002 | 5.13 |
Col4a1 |
collagen, type IV, alpha 1 |
3321 |
0.23 |
chr7_96421299_96421521 | 5.13 |
Rps11-ps5 |
ribosomal protein S11, pseudogene 5 |
14607 |
0.24 |
chr1_78375165_78375323 | 5.09 |
Gm37884 |
predicted gene, 37884 |
370 |
0.87 |
chr16_90921543_90921825 | 5.07 |
Gm49727 |
predicted gene, 49727 |
3848 |
0.12 |
chr6_136789326_136789841 | 5.06 |
Gucy2c |
guanylate cyclase 2c |
7818 |
0.1 |
chr11_115215143_115215414 | 5.06 |
Nat9 |
N-acetyltransferase 9 (GCN5-related, putative) |
27419 |
0.09 |
chr4_126512394_126512660 | 5.04 |
Ago4 |
argonaute RISC catalytic subunit 4 |
4385 |
0.12 |
chr6_113686612_113686770 | 5.02 |
Gm43912 |
predicted gene, 43912 |
3164 |
0.09 |
chr4_86391388_86391557 | 5.01 |
Gm12550 |
predicted gene 12550 |
50869 |
0.15 |
chr13_60702019_60702318 | 5.00 |
Dapk1 |
death associated protein kinase 1 |
5755 |
0.2 |
chr7_131882978_131883140 | 5.00 |
Gm44548 |
predicted gene 44548 |
49595 |
0.12 |
chr7_74458448_74458599 | 4.99 |
Slco3a1 |
solute carrier organic anion transporter family, member 3a1 |
45812 |
0.17 |
chr11_55405684_55405936 | 4.99 |
Sparc |
secreted acidic cysteine rich glycoprotein |
3645 |
0.2 |
chr9_63757305_63758776 | 4.98 |
Smad3 |
SMAD family member 3 |
46 |
0.98 |
chr2_103608163_103608322 | 4.96 |
Abtb2 |
ankyrin repeat and BTB (POZ) domain containing 2 |
41932 |
0.14 |
chr15_36460470_36460815 | 4.93 |
Gm49224 |
predicted gene, 49224 |
23951 |
0.13 |
chr6_146980054_146980231 | 4.91 |
Ppfibp1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
3659 |
0.17 |
chr12_85397269_85397420 | 4.89 |
Tmed10 |
transmembrane p24 trafficking protein 10 |
22497 |
0.11 |
chr19_55806776_55806927 | 4.89 |
Ppnr |
per-pentamer repeat gene |
34821 |
0.2 |
chr4_135307291_135307625 | 4.87 |
Gm12984 |
predicted gene 12984 |
109 |
0.85 |
chr11_109681669_109681823 | 4.87 |
Fam20a |
family with sequence similarity 20, member A |
1233 |
0.44 |
chrX_36852723_36852874 | 4.86 |
C330007P06Rik |
RIKEN cDNA C330007P06 gene |
4214 |
0.14 |
chr8_33888096_33888251 | 4.86 |
Rbpms |
RNA binding protein gene with multiple splicing |
1609 |
0.33 |
chr7_16793470_16793621 | 4.86 |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
368 |
0.77 |
chr18_80749307_80749458 | 4.86 |
Atp9b |
ATPase, class II, type 9B |
3614 |
0.23 |
chr3_102756028_102756179 | 4.86 |
Tspan2 |
tetraspanin 2 |
3207 |
0.16 |
chr2_157074681_157075005 | 4.86 |
Soga1 |
suppressor of glucose, autophagy associated 1 |
4411 |
0.16 |
chr2_167351645_167351796 | 4.86 |
B4galt5 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5 |
2537 |
0.28 |
chr4_120726097_120726307 | 4.85 |
Kcnq4 |
potassium voltage-gated channel, subfamily Q, member 4 |
21046 |
0.12 |
chr13_47193398_47193561 | 4.84 |
Rnf144b |
ring finger protein 144B |
346 |
0.87 |
chr9_54597188_54597381 | 4.81 |
Idh3a |
isocitrate dehydrogenase 3 (NAD+) alpha |
2190 |
0.28 |
chr7_128321702_128321853 | 4.81 |
Gm6916 |
predicted pseudogene 6916 |
6993 |
0.11 |
chr6_34609956_34610412 | 4.80 |
Cald1 |
caldesmon 1 |
11564 |
0.19 |
chr5_130192469_130192665 | 4.78 |
Ndufa12-ps |
NADH:ubiquinone oxidoreductase subunit A12, pseudogene |
4172 |
0.12 |
chr7_127768560_127769629 | 4.76 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
721 |
0.4 |
chr1_74009054_74009231 | 4.71 |
Tns1 |
tensin 1 |
7280 |
0.24 |
chr11_76893633_76893980 | 4.70 |
Tmigd1 |
transmembrane and immunoglobulin domain containing 1 |
8353 |
0.18 |
chr5_36253280_36253431 | 4.70 |
Sorcs2 |
sortilin-related VPS10 domain containing receptor 2 |
15124 |
0.21 |
chr13_37657358_37657585 | 4.70 |
AI463229 |
expressed sequence AI463229 |
9071 |
0.12 |
chr15_91642997_91643313 | 4.70 |
Lrrk2 |
leucine-rich repeat kinase 2 |
30020 |
0.16 |
chr15_32264977_32265266 | 4.67 |
Sema5a |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
20018 |
0.16 |
chr11_106896868_106897034 | 4.67 |
Smurf2 |
SMAD specific E3 ubiquitin protein ligase 2 |
23324 |
0.13 |
chr6_86653141_86653292 | 4.66 |
Mxd1 |
MAX dimerization protein 1 |
9889 |
0.11 |
chr7_112289469_112289834 | 4.66 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
18352 |
0.26 |
chr18_21051783_21051934 | 4.64 |
Mep1b |
meprin 1 beta |
10065 |
0.2 |
chr12_69453547_69453698 | 4.62 |
5830428M24Rik |
RIKEN cDNA 5830428M24 gene |
13770 |
0.16 |
chr8_70468852_70469004 | 4.61 |
Klhl26 |
kelch-like 26 |
6970 |
0.09 |
chr17_71087452_71087692 | 4.61 |
Myom1 |
myomesin 1 |
1176 |
0.45 |
chr10_42088991_42089348 | 4.60 |
Tdg-ps2 |
thymine DNA glycosylase, pseudogene 2 |
33863 |
0.18 |
chr17_31897136_31897482 | 4.60 |
Gm50000 |
predicted gene, 50000 |
1869 |
0.26 |
chr7_109191268_109192295 | 4.60 |
Lmo1 |
LIM domain only 1 |
16574 |
0.17 |
chr11_58969728_58969952 | 4.56 |
Trim17 |
tripartite motif-containing 17 |
6038 |
0.07 |
chr5_66534141_66534300 | 4.56 |
Gm43795 |
predicted gene 43795 |
59 |
0.97 |
chr4_116048186_116048343 | 4.55 |
Nsun4 |
NOL1/NOP2/Sun domain family, member 4 |
95 |
0.95 |
chr16_57401873_57402024 | 4.54 |
Filip1l |
filamin A interacting protein 1-like |
48671 |
0.12 |
chr6_67481043_67481194 | 4.54 |
Il23r |
interleukin 23 receptor |
10737 |
0.15 |
chr11_105352233_105352567 | 4.54 |
Gm11638 |
predicted gene 11638 |
10852 |
0.17 |
chr7_80824232_80824654 | 4.54 |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
1531 |
0.35 |
chr4_105218223_105218374 | 4.53 |
Plpp3 |
phospholipid phosphatase 3 |
60951 |
0.14 |
chr2_163809759_163809910 | 4.51 |
Ccn5 |
cellular communication network factor 5 |
11027 |
0.18 |
chr8_81638586_81638737 | 4.50 |
4930579O11Rik |
RIKEN cDNA 4930579O11 gene |
28411 |
0.23 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 8.9 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
2.7 | 10.8 | GO:0060596 | mammary placode formation(GO:0060596) |
2.1 | 6.2 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
1.9 | 5.8 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.8 | 5.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.8 | 7.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.8 | 3.5 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.6 | 4.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.6 | 6.4 | GO:0070836 | caveola assembly(GO:0070836) |
1.5 | 9.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.5 | 7.6 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.5 | 6.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.5 | 4.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.4 | 6.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.3 | 3.8 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
1.2 | 6.1 | GO:0030578 | PML body organization(GO:0030578) |
1.2 | 12.1 | GO:0032060 | bleb assembly(GO:0032060) |
1.2 | 3.6 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.2 | 2.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.2 | 3.5 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.1 | 3.4 | GO:0036394 | amylase secretion(GO:0036394) |
1.1 | 3.4 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
1.1 | 2.3 | GO:0060594 | mammary gland specification(GO:0060594) |
1.1 | 5.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.1 | 4.5 | GO:0002159 | desmosome assembly(GO:0002159) |
1.1 | 3.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.1 | 1.1 | GO:0070384 | Harderian gland development(GO:0070384) |
1.1 | 5.5 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.1 | 3.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.1 | 4.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.1 | 6.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.0 | 10.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.0 | 3.0 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
1.0 | 5.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.0 | 2.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.0 | 3.0 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
1.0 | 2.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.0 | 4.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.0 | 2.9 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
1.0 | 2.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.0 | 2.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.0 | 3.8 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.9 | 1.9 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.9 | 2.8 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.9 | 2.8 | GO:0032439 | endosome localization(GO:0032439) |
0.9 | 0.9 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.9 | 2.8 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.9 | 1.8 | GO:0003166 | bundle of His development(GO:0003166) |
0.9 | 1.8 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.9 | 1.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.9 | 2.7 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.9 | 3.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.9 | 1.8 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.9 | 2.6 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.9 | 2.6 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.9 | 2.6 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.9 | 2.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.9 | 4.3 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.8 | 2.5 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.8 | 4.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.8 | 0.8 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.8 | 6.6 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.8 | 2.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.8 | 7.4 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.8 | 2.5 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.8 | 6.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.8 | 3.3 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.8 | 2.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.8 | 1.6 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.8 | 1.6 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.8 | 3.9 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.8 | 4.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.8 | 3.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.8 | 3.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.8 | 1.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.7 | 1.5 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.7 | 1.5 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.7 | 2.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.7 | 4.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.7 | 2.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.7 | 4.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.7 | 4.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.7 | 2.8 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.7 | 4.8 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.7 | 4.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.7 | 2.7 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.7 | 1.4 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.7 | 2.0 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.7 | 2.7 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.7 | 2.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.7 | 2.0 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.7 | 4.0 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.7 | 2.7 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.7 | 0.7 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.7 | 1.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.7 | 0.7 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.7 | 2.6 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.7 | 2.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.7 | 6.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.6 | 6.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.6 | 3.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.6 | 1.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.6 | 0.6 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.6 | 12.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.6 | 1.9 | GO:1903416 | response to glycoside(GO:1903416) |
0.6 | 1.3 | GO:0003383 | apical constriction(GO:0003383) |
0.6 | 1.9 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.6 | 3.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.6 | 1.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.6 | 2.5 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.6 | 1.9 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.6 | 2.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.6 | 3.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.6 | 1.2 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
0.6 | 2.4 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.6 | 1.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.6 | 1.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.6 | 3.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.6 | 1.8 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.6 | 1.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.6 | 2.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.6 | 1.7 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.6 | 2.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.6 | 2.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.6 | 4.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.6 | 1.1 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.6 | 0.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.6 | 1.7 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.6 | 4.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.6 | 1.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.6 | 1.7 | GO:0042938 | dipeptide transport(GO:0042938) |
0.6 | 1.7 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.6 | 1.7 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.5 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.5 | 2.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.5 | 3.3 | GO:0030575 | nuclear body organization(GO:0030575) |
0.5 | 3.8 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.5 | 0.5 | GO:0031033 | myosin filament organization(GO:0031033) |
0.5 | 3.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.5 | 2.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.5 | 1.6 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.5 | 1.6 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.5 | 2.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 1.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.5 | 2.1 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.5 | 1.6 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.5 | 2.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.5 | 1.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.5 | 2.6 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.5 | 3.1 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.5 | 1.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.5 | 3.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.5 | 1.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.5 | 1.0 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.5 | 1.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.5 | 2.0 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.5 | 2.0 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.5 | 2.0 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.5 | 7.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.5 | 1.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 3.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.5 | 2.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 1.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.5 | 1.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 | 2.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.5 | 4.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.5 | 1.0 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.5 | 2.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 2.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.5 | 3.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.5 | 0.5 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.5 | 1.9 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.5 | 1.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.5 | 2.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.5 | 5.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.5 | 1.9 | GO:0001705 | ectoderm formation(GO:0001705) |
0.5 | 0.9 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.5 | 1.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.5 | 1.4 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.5 | 1.4 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.5 | 1.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.5 | 0.9 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.5 | 0.5 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.4 | 1.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 1.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 0.9 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.4 | 1.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.4 | 1.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 2.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 2.6 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.4 | 0.4 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.4 | 5.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.4 | 0.4 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.4 | 0.9 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.4 | 2.6 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.4 | 4.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 1.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.4 | 1.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 | 1.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.4 | 1.7 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.4 | 2.1 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.4 | 1.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 0.8 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.4 | 1.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 1.7 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.4 | 3.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.4 | 1.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.4 | 1.7 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 1.6 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.4 | 0.8 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.4 | 2.8 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.4 | 0.8 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 1.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.4 | 0.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 2.0 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.4 | 3.6 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.4 | 0.8 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.4 | 1.6 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.4 | 1.2 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.4 | 1.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 2.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.4 | 0.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.4 | 0.8 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.4 | 0.8 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.4 | 2.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.4 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.4 | 0.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.4 | 0.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.4 | 1.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.4 | 1.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 1.9 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.4 | 1.5 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.4 | 1.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 0.4 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
0.4 | 1.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.4 | 1.1 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.4 | 1.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 1.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.4 | 1.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.4 | 1.5 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.4 | 3.3 | GO:1902287 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.4 | 1.5 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 0.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 2.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 2.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.4 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.4 | 1.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 1.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.4 | 1.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 1.5 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.4 | 1.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.4 | 0.7 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.4 | 1.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.4 | 0.7 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.4 | 0.4 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.4 | 3.2 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.4 | 1.8 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.4 | 1.4 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 0.4 | GO:0001840 | neural plate development(GO:0001840) |
0.3 | 1.0 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.3 | 1.4 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.3 | 0.7 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.3 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 2.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.3 | 0.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.3 | 0.3 | GO:0009136 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.3 | 0.3 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.3 | 0.7 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.3 | 0.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.3 | 0.7 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.3 | 0.3 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 2.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 2.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 1.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 0.7 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.3 | 5.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 3.0 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 1.3 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 0.3 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.3 | 0.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 1.3 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 1.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 1.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 1.6 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.3 | 0.7 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.3 | 1.3 | GO:0031506 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.3 | 0.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 0.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.3 | 1.6 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.3 | 1.3 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.3 | 1.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.3 | 3.8 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.3 | 1.0 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 1.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.3 | 1.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 0.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.3 | 0.3 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.3 | 1.0 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 0.6 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.3 | 0.3 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.3 | 2.8 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.3 | 1.3 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.3 | 0.9 | GO:1902075 | cellular response to salt(GO:1902075) |
0.3 | 0.3 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 1.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.3 | 0.9 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.3 | 0.3 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.3 | 0.3 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.3 | 0.3 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.3 | 0.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.3 | 0.6 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.3 | 0.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 1.2 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 0.9 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.3 | 0.3 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.3 | 0.3 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 0.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 0.3 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.3 | 1.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.3 | 0.9 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 6.3 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.3 | 1.5 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.3 | 0.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.3 | 0.3 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.3 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 3.5 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.3 | 1.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.3 | 1.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 2.0 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.3 | 1.2 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.3 | 2.3 | GO:0033572 | transferrin transport(GO:0033572) |
0.3 | 0.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.3 | 1.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.3 | 0.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 0.9 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.3 | 4.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 0.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.3 | 1.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.3 | 0.6 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.3 | 0.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 1.7 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.3 | 2.6 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.3 | 0.9 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 0.9 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.3 | 2.0 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 0.9 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.3 | 2.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 1.1 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.3 | 2.5 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.3 | 0.3 | GO:0090194 | negative regulation of prostatic bud formation(GO:0060686) negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.3 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 0.3 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.3 | 0.8 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 0.8 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.3 | 0.6 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.3 | 0.6 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.3 | 0.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.3 | 3.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.3 | 0.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 4.7 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.3 | 0.8 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.3 | 0.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 1.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 1.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 0.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 0.5 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 1.9 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.3 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 0.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.3 | 1.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.8 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.3 | 1.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 1.9 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.3 | 1.9 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.3 | 4.9 | GO:0001945 | lymph vessel development(GO:0001945) |
0.3 | 3.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 0.3 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.3 | 1.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 1.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.3 | 2.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 0.8 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.3 | 2.1 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.3 | 0.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.3 | 1.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 1.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 4.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 0.3 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.3 | 2.4 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.3 | 0.8 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.3 | 0.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.3 | 1.0 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.3 | 3.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 1.0 | GO:0046959 | habituation(GO:0046959) |
0.3 | 0.3 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.3 | 2.1 | GO:0043217 | myelin maintenance(GO:0043217) |
0.3 | 1.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 1.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.3 | 0.5 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.3 | 0.8 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.3 | 0.5 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.3 | 0.3 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.3 | 1.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.3 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 0.3 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.3 | 0.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 2.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.8 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 2.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 1.0 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.3 | 0.8 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 0.7 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
0.2 | 0.7 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 1.0 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.2 | 0.5 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 1.0 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.2 | 0.2 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.2 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.5 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.2 | 0.7 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.2 | 0.5 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
0.2 | 1.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 3.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 1.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 1.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 1.2 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.2 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 1.0 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 2.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 1.0 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.2 | 0.7 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.7 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 0.7 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.2 | 0.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.7 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.2 | 0.9 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 1.9 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 0.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 0.5 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.2 | 0.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 4.2 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 0.9 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.7 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.2 | 0.2 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.2 | 2.3 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.2 | 0.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.2 | GO:0019755 | one-carbon compound transport(GO:0019755) |
0.2 | 0.2 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.2 | 0.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.7 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.2 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 1.8 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.2 | 2.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.9 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.2 | 0.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 2.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.5 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 1.6 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.2 | 0.9 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 2.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 1.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.2 | 1.8 | GO:0033280 | response to vitamin D(GO:0033280) |
0.2 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 0.2 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.2 | 2.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 1.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.4 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.2 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 0.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.2 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.2 | 0.7 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 0.9 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 0.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 1.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.9 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.2 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.2 | 0.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 1.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 1.3 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.2 | 3.0 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 2.4 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.2 | 1.7 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.2 | 1.5 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.4 | GO:0034165 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 0.4 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.2 | 0.6 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 0.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 0.4 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.2 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 0.6 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 1.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.2 | 1.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 1.3 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 1.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 0.2 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.2 | 1.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 0.6 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 1.5 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 1.7 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 0.8 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.2 | 0.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 1.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 0.2 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 1.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.6 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.2 | 0.2 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 1.0 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 0.2 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 1.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 1.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.6 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.2 | GO:1903798 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 0.8 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.2 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.2 | 0.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.2 | 2.7 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 0.2 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.2 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 1.6 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 1.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.2 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 1.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 0.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.2 | 1.0 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 0.6 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 1.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 2.3 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 1.5 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.2 | 0.4 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.2 | 0.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 3.0 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.2 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.2 | 1.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 1.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.4 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.2 | 1.1 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.2 | 0.6 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.2 | 1.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 4.8 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 3.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 1.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.2 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 1.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 2.7 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.2 | 2.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 0.2 | GO:1905065 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.2 | 0.5 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 4.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 2.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 0.4 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.4 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 0.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 1.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 2.0 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.2 | 2.1 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.2 | 0.5 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 1.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 1.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.2 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.2 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.2 | 0.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.5 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 1.0 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.2 | 0.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.5 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 1.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 1.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 0.7 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.2 | 0.3 | GO:0046689 | response to mercury ion(GO:0046689) |
0.2 | 5.3 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 1.5 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 0.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 0.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.5 | GO:0010226 | response to lithium ion(GO:0010226) |
0.2 | 0.3 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.2 | 0.3 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.2 | 0.8 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.2 | 0.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 1.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 2.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.2 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.2 | 0.5 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.2 | 0.3 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.2 | 0.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 1.1 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.2 | 0.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.2 | 0.7 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.2 | 0.7 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.2 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.2 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 1.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 0.5 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.6 | GO:0032824 | peptidoglycan metabolic process(GO:0000270) natural killer cell differentiation involved in immune response(GO:0002325) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.2 | 0.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 0.6 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.2 | 1.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 0.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.2 | 1.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.2 | GO:0033483 | gas homeostasis(GO:0033483) |
0.2 | 0.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.2 | 1.7 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 0.2 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.2 | 0.8 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.2 | 0.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 1.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.3 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.2 | 1.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.2 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.5 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.2 | 0.9 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.2 | 0.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.2 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.2 | 2.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.8 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.2 | 1.2 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.2 | 0.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.2 | 1.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 1.3 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.1 | 0.3 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.3 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.6 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.4 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.6 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.3 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 2.2 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.7 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.9 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.1 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 2.9 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 1.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.1 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.1 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.6 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.7 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 1.4 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.3 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.4 | GO:0097531 | mast cell migration(GO:0097531) |
0.1 | 0.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.4 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.1 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.1 | 0.1 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.3 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 1.3 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 2.1 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 0.5 | GO:0061180 | mammary gland epithelium development(GO:0061180) |
0.1 | 1.1 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.5 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.1 | 0.9 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.8 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.3 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 1.3 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 1.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.1 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.8 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 1.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.3 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.3 | GO:2000427 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.9 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.9 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.3 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.6 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.8 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.1 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 1.8 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 1.1 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.1 | 0.1 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.1 | 0.7 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.1 | 1.6 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.4 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.6 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.6 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.2 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.7 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 2.2 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 1.0 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.4 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 1.1 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 1.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 1.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.5 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.3 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.1 | GO:1904748 | regulation of apoptotic process involved in development(GO:1904748) |
0.1 | 0.1 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.1 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.6 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.3 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.0 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 1.8 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.5 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 1.6 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.3 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.3 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 1.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 5.3 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.1 | 0.4 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.1 | 0.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 2.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.3 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.1 | GO:0050996 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) positive regulation of lipid catabolic process(GO:0050996) |
0.1 | 0.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.3 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.3 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.6 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.1 | 0.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 3.8 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.1 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.1 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.6 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.8 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 1.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.7 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.5 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.1 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.8 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 1.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.3 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.8 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 2.2 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.8 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.7 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 1.3 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 2.4 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.6 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:0018214 | protein carboxylation(GO:0018214) |
0.1 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.1 | 0.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.6 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.2 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 1.0 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.4 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.7 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.5 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 0.7 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 1.7 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.4 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.2 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.2 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.2 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.6 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.3 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.1 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.1 | 0.3 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.8 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
0.1 | 0.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 0.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.3 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.4 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.2 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.4 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:1904478 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.1 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.6 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 1.3 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.1 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 1.4 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.1 | GO:0010224 | response to UV-B(GO:0010224) |
0.1 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.2 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.8 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.1 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.1 | 0.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 2.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 3.4 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.5 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.2 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.1 | 0.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 1.7 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.1 | 2.7 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.3 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 0.7 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.1 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.1 | 0.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.1 | 0.2 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.5 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.1 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.1 | 0.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.5 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.3 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
0.1 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.1 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.1 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.5 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.1 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.4 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.6 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0001660 | fever generation(GO:0001660) |
0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.4 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.7 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 1.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.3 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.3 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.5 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.1 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.1 | 0.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.9 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.1 | 0.2 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.1 | 0.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.6 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.1 | 0.3 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.3 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 0.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.1 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 3.2 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.2 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.2 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.5 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.1 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.1 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.1 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.4 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.1 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 | 0.2 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.1 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.1 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.3 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.1 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.0 | 0.5 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.0 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 1.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.0 | GO:0008212 | mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.0 | 0.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.3 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.0 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.0 | 0.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.0 | 0.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.5 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.0 | 0.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.2 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.0 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.1 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.0 | GO:0048880 | sensory system development(GO:0048880) |
0.0 | 0.0 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.0 | 0.0 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.0 | 0.0 | GO:0044116 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.0 | 0.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 1.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.8 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.1 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.0 | 0.0 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.0 | 0.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.0 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.0 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.0 | 0.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.0 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.1 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) |
0.0 | 0.9 | GO:0070167 | regulation of biomineral tissue development(GO:0070167) |
0.0 | 0.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.0 | GO:0021612 | facial nerve structural organization(GO:0021612) |
0.0 | 0.1 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.9 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.0 | 0.0 | GO:1903429 | regulation of cell maturation(GO:1903429) |
0.0 | 0.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.0 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.2 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 2.0 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.0 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.0 | 1.0 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.6 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.4 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.0 | 0.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.0 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.0 | 0.1 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.3 | GO:0007129 | synapsis(GO:0007129) |
0.0 | 0.2 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.0 | 0.1 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 1.2 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.1 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 | 0.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0015879 | carnitine transport(GO:0015879) |
0.0 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.0 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.2 | GO:0001825 | blastocyst formation(GO:0001825) |
0.0 | 0.6 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.0 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.0 | 0.0 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
0.0 | 0.0 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.0 | 0.0 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.0 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 1.5 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.0 | 0.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.3 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.1 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.0 | 0.0 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.0 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.0 | 0.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.0 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.2 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.0 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.0 | 0.0 | GO:0072677 | eosinophil migration(GO:0072677) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) spindle assembly involved in meiosis(GO:0090306) |
0.0 | 0.0 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.1 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.0 | GO:0060443 | mammary gland morphogenesis(GO:0060443) |
0.0 | 0.0 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) |
0.0 | 0.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.0 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.0 | 0.0 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.0 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.0 | 0.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.0 | GO:0031128 | developmental induction(GO:0031128) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 8.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.8 | 5.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.7 | 5.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.6 | 6.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.3 | 3.9 | GO:0097513 | myosin II filament(GO:0097513) |
1.3 | 7.8 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.2 | 3.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.0 | 3.1 | GO:0097443 | sorting endosome(GO:0097443) |
1.0 | 2.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.0 | 3.9 | GO:1990357 | terminal web(GO:1990357) |
1.0 | 2.9 | GO:0043293 | apoptosome(GO:0043293) |
0.9 | 2.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.9 | 2.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.9 | 2.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.8 | 7.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.8 | 6.2 | GO:0005861 | troponin complex(GO:0005861) |
0.8 | 1.6 | GO:0001739 | sex chromatin(GO:0001739) |
0.8 | 2.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.8 | 3.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.7 | 8.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 3.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.7 | 3.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.7 | 9.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 12.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.7 | 2.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.7 | 2.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.7 | 2.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.7 | 2.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.7 | 4.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.7 | 5.2 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 3.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 1.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.6 | 1.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 6.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.6 | 3.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.6 | 1.8 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 1.7 | GO:1990423 | RZZ complex(GO:1990423) |
0.6 | 1.7 | GO:0005745 | m-AAA complex(GO:0005745) |
0.6 | 4.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.6 | 2.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 0.6 | GO:0032432 | actin filament bundle(GO:0032432) |
0.5 | 2.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 2.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.5 | 4.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.5 | 2.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 2.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.5 | 1.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.5 | 1.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 1.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.5 | 2.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 1.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 1.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.5 | 1.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.5 | 2.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 4.4 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.5 | 2.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.5 | 1.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.5 | 7.1 | GO:0043218 | compact myelin(GO:0043218) |
0.5 | 2.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.5 | 1.8 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 6.3 | GO:0036379 | myofilament(GO:0036379) |
0.4 | 3.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.4 | 4.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 20.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.4 | 1.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 0.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 2.8 | GO:0032982 | myosin filament(GO:0032982) |
0.4 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 1.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.4 | 2.7 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 3.5 | GO:0042641 | actomyosin(GO:0042641) |
0.4 | 4.2 | GO:0002102 | podosome(GO:0002102) |
0.4 | 1.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 3.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 1.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 1.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.4 | 1.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 1.4 | GO:0044308 | axonal spine(GO:0044308) |
0.3 | 1.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 3.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 2.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 1.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 8.8 | GO:0031672 | A band(GO:0031672) |
0.3 | 1.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.3 | 7.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 2.9 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 1.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 1.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 0.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 4.9 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 3.1 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 2.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 3.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 1.8 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.3 | 1.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 0.9 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 3.5 | GO:0043034 | costamere(GO:0043034) |
0.3 | 15.8 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 0.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 1.4 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 1.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 1.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 0.8 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 1.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.3 | 1.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 0.8 | GO:0005712 | chiasma(GO:0005712) |
0.3 | 1.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 0.8 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 2.8 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.3 | 1.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 1.3 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 1.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.3 | 5.3 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 0.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 3.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 3.4 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 2.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 1.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.9 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 0.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 0.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 3.2 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 0.5 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 4.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 0.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 2.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 3.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 0.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 0.6 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 1.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 1.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 1.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 2.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 0.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.8 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 1.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 1.0 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 3.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 0.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 1.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 3.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 7.5 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 1.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 1.0 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 3.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 1.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 6.1 | GO:0031674 | I band(GO:0031674) |
0.2 | 0.2 | GO:0005818 | aster(GO:0005818) |
0.2 | 4.2 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.9 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 0.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 3.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 1.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 1.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 2.6 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 1.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 5.8 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 10.2 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 0.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 1.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 1.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 11.7 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 6.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 4.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.8 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 0.6 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 1.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 2.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 38.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 7.2 | GO:0016528 | sarcoplasm(GO:0016528) |
0.2 | 0.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 1.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 0.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 1.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 1.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.6 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 3.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 1.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.6 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.6 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 2.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 1.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 1.8 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.7 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 1.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.5 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 7.4 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 2.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.3 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.5 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 0.9 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 8.0 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 4.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 1.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 2.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 1.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.0 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.6 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 10.1 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 2.2 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 5.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 24.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 2.5 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.9 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 27.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.9 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 3.0 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.8 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.8 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 2.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.6 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 2.0 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 0.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.1 | 1.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 2.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.3 | GO:0001939 | female pronucleus(GO:0001939) male pronucleus(GO:0001940) |
0.1 | 1.6 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.4 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 2.3 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.2 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.1 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 3.3 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.6 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 1.1 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 4.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 1.2 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 0.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 1.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 0.0 | GO:1903349 | omegasome membrane(GO:1903349) |
0.0 | 0.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 1.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.0 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.0 | 0.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 1.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.6 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.8 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.0 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 1.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
2.1 | 2.1 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.9 | 11.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.8 | 5.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.5 | 10.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.4 | 4.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.3 | 9.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
1.3 | 6.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.3 | 3.9 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.2 | 3.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.1 | 3.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.0 | 6.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.0 | 10.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.0 | 4.8 | GO:0031013 | troponin I binding(GO:0031013) |
0.9 | 0.9 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.9 | 0.9 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.9 | 10.8 | GO:0044548 | S100 protein binding(GO:0044548) |
0.9 | 3.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.9 | 9.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.9 | 3.5 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.9 | 4.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.8 | 2.5 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.8 | 2.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.8 | 10.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.8 | 9.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.8 | 3.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 2.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.7 | 2.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 4.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.7 | 2.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.7 | 6.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.7 | 4.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.6 | 0.6 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.6 | 2.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.6 | 1.9 | GO:0051373 | FATZ binding(GO:0051373) |
0.6 | 4.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.6 | 3.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.6 | 3.7 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.6 | 1.8 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.6 | 3.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.6 | 4.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.6 | 5.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.6 | 1.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.6 | 1.8 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.6 | 1.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.6 | 5.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.6 | 2.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 2.3 | GO:0071253 | connexin binding(GO:0071253) |
0.6 | 1.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.6 | 3.9 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 1.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 0.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.6 | 3.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.5 | 2.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 3.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.5 | 4.3 | GO:0008430 | selenium binding(GO:0008430) |
0.5 | 1.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 0.5 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.5 | 1.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.5 | 5.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.5 | 4.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 2.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.5 | 1.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 1.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.5 | 8.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 1.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.5 | 1.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 1.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.5 | 4.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.5 | 2.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.5 | 1.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 0.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.5 | 2.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 5.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.5 | 1.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.4 | 6.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 1.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 1.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 4.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 11.9 | GO:0043236 | laminin binding(GO:0043236) |
0.4 | 3.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 4.7 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.4 | 2.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 4.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.4 | 3.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 1.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 2.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 3.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 1.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 0.4 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.4 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 2.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 2.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 0.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 4.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 3.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.4 | 2.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 2.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 2.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.4 | 1.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.4 | 3.5 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.4 | 1.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.4 | 0.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 1.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.4 | 1.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 3.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 0.4 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.4 | 1.5 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.4 | 2.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 1.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 1.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 1.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.4 | 1.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 1.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.4 | 4.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 1.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 2.5 | GO:0018647 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.4 | 1.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 3.2 | GO:0034847 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 5.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 2.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.4 | 1.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 1.7 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.3 | 2.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 1.7 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 0.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 1.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 1.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 1.0 | GO:0035877 | death effector domain binding(GO:0035877) |
0.3 | 2.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 3.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 1.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 0.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 2.0 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.3 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 1.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 4.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 1.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 1.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.3 | 5.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.3 | 1.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 1.9 | GO:0018499 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.3 | 2.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 0.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 0.9 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.3 | 1.2 | GO:0034547 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 0.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 2.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 5.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 1.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 2.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 0.6 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 0.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 1.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 4.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 1.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 0.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 1.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 1.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 2.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 6.2 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 1.4 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.3 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 1.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 2.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.3 | 0.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 1.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.3 | 1.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 0.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 1.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 1.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 0.8 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 1.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 2.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 1.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 1.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 9.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 2.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 2.8 | GO:0052835 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.3 | 0.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 1.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.7 | GO:0030546 | receptor activator activity(GO:0030546) |
0.2 | 2.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 1.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.7 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 2.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 13.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 1.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 1.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 0.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 0.9 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.9 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 6.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 1.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 2.6 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 0.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 1.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.9 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 1.7 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 1.7 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 3.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 1.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 1.0 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.0 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 0.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 3.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 1.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 1.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 2.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 0.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 0.6 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 0.6 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.2 | 0.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 1.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 5.9 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.2 | 1.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.8 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.2 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.2 | 1.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 2.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 0.2 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.2 | 0.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 1.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 1.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 2.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.6 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 1.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 5.1 | GO:0052693 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.2 | 0.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.5 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.7 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 1.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 1.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 4.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.9 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.5 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 0.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 2.2 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 0.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 1.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.2 | 1.4 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 0.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 2.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.5 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 2.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.3 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.2 | 0.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 2.0 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.2 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 0.6 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.2 | 0.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 1.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 7.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 0.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 0.2 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 1.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 5.1 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.2 | 0.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 1.1 | GO:0052687 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 1.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.8 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 0.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.7 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 1.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 15.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.3 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.1 | 1.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 1.5 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.6 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 1.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.6 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 1.8 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 1.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 2.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 2.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 3.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 1.3 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 6.8 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.5 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.1 | 1.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 6.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.5 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.4 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 1.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.7 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 7.6 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 1.1 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 5.6 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 2.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 2.1 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.5 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.5 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 10.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 2.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 2.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 1.1 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 2.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 1.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 1.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.7 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 2.9 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 2.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 1.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.7 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 2.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.4 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.1 | 0.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.1 | 1.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 1.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 1.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 1.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.6 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 2.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 2.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 2.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 1.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 1.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 2.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 1.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 2.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 3.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 4.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.5 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 2.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.1 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.1 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.2 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 1.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.4 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.2 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.8 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 4.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 0.1 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.1 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.1 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 4.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.1 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 1.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 2.5 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 2.4 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.1 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 2.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 4.0 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 1.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 1.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.0 | 1.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.1 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.1 | GO:0035174 | histone serine kinase activity(GO:0035174) histone kinase activity (H3-S10 specific)(GO:0035175) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.2 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 1.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.5 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 1.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 4.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.2 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.0 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.0 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.3 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.5 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 3.5 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 1.4 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.0 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 0.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.1 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 1.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.3 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.0 | GO:0018569 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.0 | GO:0005222 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cAMP activated cation channel activity(GO:0005222) cyclic nucleotide-gated ion channel activity(GO:0043855) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 1.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.0 | 10.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.9 | 10.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.8 | 13.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 19.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.6 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.6 | 6.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 14.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.5 | 8.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.5 | 4.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.5 | 10.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 16.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 1.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.5 | 3.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 12.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 15.6 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 0.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 17.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 1.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 3.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 4.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 8.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 1.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 5.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 8.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 12.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 5.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 2.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 6.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 5.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 3.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 6.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 0.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 0.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 3.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 4.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 0.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 1.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 6.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 2.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 3.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 1.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 3.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 2.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 1.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 0.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 1.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 0.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 24.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 1.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 1.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 4.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 3.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 0.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 2.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 2.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 1.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 7.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 4.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 2.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 2.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 4.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 6.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 15.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 2.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.7 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 3.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 0.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 14.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 3.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 1.0 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 1.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.2 | 2.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.8 | 22.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.7 | 5.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.7 | 6.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.7 | 6.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.7 | 7.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.7 | 7.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.7 | 12.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.7 | 16.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.6 | 1.9 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.6 | 0.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.6 | 5.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.5 | 0.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.5 | 0.9 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.4 | 12.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.4 | 3.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.4 | 29.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.4 | 3.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 8.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 4.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 4.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 4.6 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.4 | 3.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.4 | 4.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.4 | 3.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 3.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 3.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 2.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 5.5 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.3 | 6.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 6.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 4.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 2.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 1.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 3.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 6.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 0.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 0.6 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.3 | 0.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 2.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 4.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 1.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 4.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 2.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 1.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 5.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 6.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 4.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 1.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 3.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 1.8 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 0.2 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 4.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 5.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 1.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 4.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 5.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 1.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 1.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 1.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 3.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 8.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 5.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 1.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 3.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 2.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 2.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 1.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 4.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 1.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 0.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 2.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 4.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 1.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 0.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 1.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 2.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 12.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.3 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 1.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 3.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 3.4 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 3.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 3.3 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 0.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.7 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 1.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 3.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.8 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 1.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.9 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 2.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 2.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 2.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 3.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 1.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 0.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 1.1 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.1 | 0.1 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.1 | 0.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 4.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 2.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 1.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 3.2 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 3.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 1.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 1.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 1.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 3.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.0 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.0 | 1.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.7 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |